Concepedia

James F. Dropinski

JF

21

Publications

2.1K

Citations

20

H-Index

1994

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

James F. Dropinski is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

1994–2020

21

Publications

21

In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)

K Bartizal, Christopher Gill, George K. Abruzzo et al. · Antimicrobial Agents and Chemotherapy · 1997 · 312 citations · Full text

, , +12

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

George K. Abruzzo, Amy Flattery, Christopher Gill et al. · Antimicrobial Agents and Chemotherapy · 1997 · 244 citations · Full text

Chemistry informer libraries: a chemoinformatics enabled approach to evaluate and advance synthetic methods

Peter S. Kutchukian, James F. Dropinski, Kevin D. Dykstra et al. · Chemical Science · 2016 · 238 citations · Full text

A multifunctional catalyst that stereoselectively assembles prodrugs

Daniel A. DiRocco, Yining Ji, Edward C. Sherer et al. · Science · 2017 · 179 citations

Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)

Richard Hajdu, R Thompson, Jon G. Sundelof et al. · Antimicrobial Agents and Chemotherapy · 1997 · 167 citations · Full text

, , +17

Rows per page

1–5 of 21